$ALC Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
on November 22, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News, ALC, ALC News, Alcon Inc., Alcon Inc. News
with 0 comments
Time:
11:01 PM
Symbol:
ALC
Source:
Business Wire
$AERI Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
on November 21, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News, ALC, ALC News, Alcon Inc., Alcon Inc. News
with 0 comments
Time:
11:01 PM
Symbol:
AERI
Source:
$AERI Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results
on November 3, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
2:01 PM
Symbol:
AERI
Source:
Business Wire
$AERI Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results
on November 3, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
2:01 PM
Symbol:
AERI
Source:
$AERI Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
on August 22, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News, ALC, ALC News, Alcon Inc., Alcon Inc. News
with 0 comments
Time:
9:18 PM
Symbol:
AERI
Source:
Business Wire
$AERI Aerie Pharmaceuticals Announces New Employee Inducement Grant
on August 15, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
6:30 AM
Symbol:
AERI
Source:
Business Wire
$AERI Aerie Pharmaceuticals Announces First Participant Dosed in the COMET-3 Study of AR-15512 for the Treatment of Dry Eye Disease
on August 1, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
4:01 PM
Symbol:
AERI
Source:
Business Wire
$AERI Aerie Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on Thursday, August 4, 2022 at 5:00 p.m. ET
on July 28, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
6:10 PM
Symbol:
AERI
Source:
Business Wire
$AERI Aerie Pharmaceuticals Announces New Employee Inducement Grant
on July 8, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
6:30 AM
Symbol:
AERI
Source:
Business Wire
$AERI Aerie Pharmaceuticals to Participate in the Jefferies Healthcare Conference on Friday, June 10, 2022 at 10:30 a.m. ET
on May 25, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
4:30 PM
Symbol:
AERI
Source:
Business Wire
$AERI Aerie Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 3:00 p.m. ET
on April 6, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
4:30 PM
Symbol:
AERI
Source:
Business Wire News Releases
$AERI Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer
on March 18, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
7:00 AM
Symbol:
AERI
Source:
Business Wire News Releases
$AERI Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Thursday, February 24, 2022 at 5:00 p.m. ET
on February 17, 2022
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
4:45 PM
Symbol:
AERI
Source:
Business Wire News Releases
$AERI Aerie Pharmaceuticals Reports Inducement Grant to Chief Executive Officer Under Nasdaq Listing Rule 5635(c)(4)
on December 22, 2021
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
4:01 PM
Symbol:
AERI
Source:
Business Wire News Releases
$AERI Aerie Pharmaceuticals Appoints Raj Kannan as Chief Executive Officer
on December 16, 2021
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
6:30 AM
Symbol:
AERI
Source:
Business Wire News Releases
$AERI Aerie Concludes Exclusive License Agreement With Santen for Rhopressa® and Rocklatan® in Europe and Several Other Regions
on December 7, 2021
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
2:00 AM
Symbol:
AERI
Source:
Business Wire News Releases
$AERI Aerie Pharmaceuticals to Participate in Upcoming Investor Conferences
on November 9, 2021
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
4:30 PM
Symbol:
AERI
Source:
Business Wire News Releases
$AERI Aerie Pharmaceuticals to Announce Third Quarter 2021 Financial Results and Host Conference Call on Thursday, November 4, 2021
on October 28, 2021
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
7:30 AM
Symbol:
AERI
Source:
Business Wire News Releases
$AERI Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Glaucoma Innovation Showcase
on October 21, 2021
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
4:01 PM
Symbol:
AERI
Source:
Business Wire News Releases
$AERI Aerie Pharmaceuticals Announces Positive Phase 3 Topline Results for Netarsudil Ophthalmic Solution 0.02% Clinical Trial in Japan
on October 12, 2021
News
and Tags: AERI, AERI News, Aerie Pharmaceuticals Inc., Aerie Pharmaceuticals Inc. News
with 0 comments
Time:
6:30 AM
Symbol:
AERI
Source:
Business Wire News Releases
12